Skip to content

Clinical trials

Completed Phase 1 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 1 Status: Completed Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20055
20067
200712
200819
200930
201028
201124
201218
201315
201421
20158
20165
20177
20183
20192
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed210

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC26
Tibotec Pharmaceuticals, Ireland25
Bristol-Myers Squibb18
Gilead Sciences12
Abbott11
GlaxoSmithKline7
Pfizer7
Tibotec BVBA6
National Institute of Allergy and Infectious Diseases (NIAID)5
Vertex Pharmaceuticals Incorporated5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C210
Hepatitis C, Chronic20
HIV Infections8
Hepatitis7
Liver Diseases5
Acquired Immunodeficiency Syndrome4
Adenoviridae Infections4
Bronchiolitis Obliterans Syndrome4
Fibrosis3
Hepatitis B3

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.